Stem Cell Cartilage Regeneration Market

Stem Cell Cartilage Regeneration Market - Size,
Share, Outlook, and Opportunity Analysis, 2018
– 2026
Stem cells therapy are emerging as an important therapeutic option in the field of cartilage
regeneration. Rapid development of stem cell-based therapy for cartilage regeneration in the
recent past has been witnessed across the world. Stem cells are mainly classified in three kinds
of cells: hematopoietic stem cell, mesenchymal stem cells, and pluripotent stem cells.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/2448
The global stem cell cartilage regeneration market size was valued at US$ 254.4 million in
2017, and is expected to witness a CAGR of 8.9% over the forecast period (2018 – 2026).
Increasing Adoption of Minimally Invasive Surgery Procedures is expected to Drive Growth of
Stem Cell Cartilage Regeneration Market
Stem cell therapy
inflammation, halt
knee replacement
(MSCs), has been
cartilage compared
for knees, minimally invasive procedure, has the potential to decrease
progression of arthritic damage, repair joint cartilage, and delay or avoid
surgery. Injection of progenitor cells, especially mesenchymal stem cells
found to be an effective and better solution for repairing degenerative
to implantation of differentiated cells such as articular cartilage.
In addition to this, other potential benefits such as lower risk and shorter duration of minimally
invasive surgery procedures are expected to fuel demand for stem cell therapy for cartilage
regeneration during the forecast period. For instance, according to NCBI 2016 report, a
minimally invasive procedure to harvest stem cells from both fat and bone marrow and inject
the concentrated cells under image guidance can be performed in 2-3 hours.
Report includes chapters which deeply display the following deliverable about industry :
• Stem Cell Cartilage Regeneration Market Research Objective and Assumption
• Stem Cell Cartilage Regeneration Market Purview - Report Description, Executive Summary,
and Coherent Opportunity Map (COM)
• Stem Cell Cartilage Regeneration Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Stem Cell Cartilage Regeneration Market, By Regions
• Stem Cell Cartilage Regeneration Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Stem Cell Cartilage Regeneration Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Stem Cell Cartilage Regeneration Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Stem Cell Cartilage Regeneration Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Market Dynamics
Growing osteoarthritis incidence among the global population is supporting the adoption of stem
cell cartilage regeneration therapy. For instance, according to November 2017, Arthritis
Foundation data findings, with the increase in global geriatric population, degenerative disease
disorders such as osteoarthritis will impact at least 130 million individuals around the globe by
2050.
Furthermore, various government agencies are focusing on policies to enhance adoption of stem
cell therapies, which is expected to drive growth of stem cell cartilage regeneration market in
the near future. For instance, in December 2016, the 21st Century Cures Act (Cures Act) was
signed into law by the U.S. FDA, thereby allowing legislation for an expedited approval path
for cellular medicines designated as regenerative medicine advanced therapies (RMATs) to
patients who are in need of it.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/2448
Stem Cell Cartilage Regeneration Market - Competitive Landscape
Key players operating in the global stem cell cartilage regeneration market include Theracell
Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris
Therapeutics, Inc., BioTissue SA, and Vericel Corporation.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Stem cells therapy are emerging as an important therapeutic option in the field of cartilage regeneration.

Download Report